ARTHUR DAVID J. (Chief Executive Officer) received a stock award from DECOY THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/5/2023ACC: 0001615219-23-000002
DirectorOfficer· Chief Executive Officer
Since Jul 2019
+20K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+20K
Price / share
—
Trade value
—
% of position
145.8%
1/3/2023
13.72K→33.72K
Total
Net shares
+20K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/3/2023 | A · Award | +20K | — | — | 145.8% | 13.72K | 33.72K |
| Total | +20K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned564.00
Common Stock
IndirectShares owned552.00
Total
1.12K indirect1.12K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 564.00 | Indirect |
| Common Stock | 552.00 | Indirect |
| Total | 1.12K | 1.12K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported